These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 21794828

  • 1. [Efficacy of adalimumab in Behçet's disease. Description of 6 cases].
    Calvo Catalá J, Campos Fernández C, Rueda Cid A, González-Cruz Cervellera MI, Baixauli Rubio A, Pastor Cubillo MD.
    Reumatol Clin; 2011; 7(4):258-61. PubMed ID: 21794828
    [Abstract] [Full Text] [Related]

  • 2. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V, Blanco R, Beltrán E, Sánchez-Bursón J, Mesquida M, Adán A, Hernandez MV, Hernandez Garfella M, Valls Pascual E, Martínez-Costa L, Sellas-Fernández A, Cordero Coma M, Díaz-Llopis M, Gallego R, Salom D, García Serrano JL, Ortego N, Herreras JM, Fonollosa A, García-Aparicio AM, Maíz O, Blanco A, Torre I, Fernández-Espartero C, Jovani V, Peiteado-Lopez D, Pato E, Cruz J, Fernández-Cid C, Aurrecoechea E, García M, Caracuel MA, Montilla C, Atanes A, Hernandez FF, Insua S, González-Suárez S, Sánchez-Andrade A, Gamero F, Linares L, Romero-Bueno F, García AJ, Almodovar R, Minguez E, Carrasco Cubero C, Olive A, Vázquez J, Ruiz Moreno O, Jiménez-Zorzo F, Manero J, Muñoz Fernández S, Rueda-Gotor J, González-Gay MA.
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [Abstract] [Full Text] [Related]

  • 3. Adalimumab for sight-threatening uveitis in Behçet's disease.
    Mushtaq B, Saeed T, Situnayake RD, Murray PI.
    Eye (Lond); 2007 Jun; 21(6):824-5. PubMed ID: 16601736
    [Abstract] [Full Text] [Related]

  • 4. Adalimumab for the treatment of Behçet's disease: experience in 19 patients.
    Perra D, Alba MA, Callejas JL, Mesquida M, Ríos-Fernández R, Adán A, Ortego N, Cervera R, Espinosa G.
    Rheumatology (Oxford); 2012 Oct; 51(10):1825-31. PubMed ID: 22723596
    [Abstract] [Full Text] [Related]

  • 5. The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
    Benitah NR, Sobrin L, Papaliodis GN.
    Semin Ophthalmol; 2011 Oct; 26(4-5):295-303. PubMed ID: 21958178
    [Abstract] [Full Text] [Related]

  • 6. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N, Mizoshita T, Sugiyama T, Togawa S, Miyaki T, Suzuki T, Tanida S, Kataoka H, Sasaki M.
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [Abstract] [Full Text] [Related]

  • 7. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E, Leccese P, Olivieri I, Latanza L.
    Clin Exp Rheumatol; 2014 Jul; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [Abstract] [Full Text] [Related]

  • 8. Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.
    Arida A, Fragiadaki K, Giavri E, Sfikakis PP.
    Semin Arthritis Rheum; 2011 Aug; 41(1):61-70. PubMed ID: 21168186
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I, D' Angelo S, Padula A, Leccese P, Mennillo GA.
    Clin Exp Rheumatol; 2009 Aug; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J, López L, Paniagua I, Intxausti JJ, Maíz O.
    Clin Exp Rheumatol; 2008 Aug; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
    Leccese P, Latanza L, D'Angelo S, Padula A, Olivieri I.
    Clin Exp Rheumatol; 2011 Aug; 29(4 Suppl 67):S93. PubMed ID: 21813069
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.
    Olivieri I, Leccese P, D'Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L.
    Clin Exp Rheumatol; 2011 Aug; 29(4 Suppl 67):S54-7. PubMed ID: 21968237
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.
    Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Behçet Network.
    J Autoimmun; 2015 Aug; 62():67-74. PubMed ID: 26162757
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
    Fabiani C, Vitale A, Emmi G, Vannozzi L, Lopalco G, Guerriero S, Orlando I, Franceschini R, Bacherini D, Cimino L, Soriano A, Frediani B, Galeazzi M, Iannone F, Tosi GM, Salvarani C, Cantarini L.
    Clin Rheumatol; 2017 Jan; 36(1):183-189. PubMed ID: 27853889
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
    Atienza-Mateo B, Calvo-Río V, Beltrán E, Martínez-Costa L, Valls-Pascual E, Hernández-Garfella M, Atanes A, Cordero-Coma M, Miquel Nolla J, Carrasco-Cubero C, Loricera J, González-Vela MC, Vegas-Revenga N, Fernández-Díaz C, Demetrio-Pablo R, Domínguez-Casas LC, Luis Martín-Varillas J, Palmou-Fontana N, Hernández JL, González-Gay MÁ, Blanco R.
    Rheumatology (Oxford); 2018 May 01; 57(5):856-864. PubMed ID: 29471416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.